Inogen (INGN) Capital Expenditures (2013 - 2026)
Inogen's (INGN) quarterly Capital Expenditures came in at -$1.5 million in Q1 2026, down 601.03% year-on-year from $292000.0 in Q1 2025, and up 23.64% on a QoQ basis from -$1.9 million in Q4 2025.
Inogen (INGN) Capital Expenditures (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Capital Expenditures data on file, last reported at -$1.5 million in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 601.03% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$3.5 million, a 1004.11% decrease from a year earlier, with the FY2025 full-year figure at -$1.8 million, down 994.42% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$1.5 million, up from -$1.9 million in the prior quarter.
- Over the last five years, Capital Expenditures for INGN reached as high as $1.7 million in Q3 2024 and fell as low as -$2.8 million in Q4 2024.
- Historically, Capital Expenditures has averaged -$126000.0 across 5 years, with a median of -$44000.0 in 2023.
- Across the five-year window, Capital Expenditures surged 3431.71% in 2022 and plunged 857.43% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at -$89000.0 in 2022, then sank by 232.58% to -$296000.0 in 2023, then plunged by 857.43% to -$2.8 million in 2024, then soared by 32.39% to -$1.9 million in 2025, then grew by 23.64% to -$1.5 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$1.5 million in Q1 2026, -$1.9 million in Q4 2025, and -$206000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -1.92 Mn |
| Dec 31, 2025 | -1.92 Mn |
| Sep 30, 2025 | -206,000.00 |
| Sep 30, 2025 | -206,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | -2.83 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -296,000.00 |
| Dec 31, 2023 | -296,000.00 |